We are a tech-enabled drug development partner.

TrialSpark brings treatments to patients faster and more efficiently by reimagining the clinical trial process.

Desktop-Sponsors Header Imagery

With a network of standardized trial sites and a best-in-class technology platform, TrialSpark runs end-to-end clinical trials as an alternative to traditional CROs. Our approach enables access to research for the 98% of physicians and patients that the industry has historically failed to include. This integrated model unlocks new patient pools and increases the speed of drug development.

COVID-19 White Paper

Our white paper explores how TrialSpark has enabled continuity of care and data integrity during the pandemic.


Our end-to-end trial capabilities

  • Sponsor 2 - Clinical Strategy

    Full-Service Clinical Strategy

    Our experienced leadership team partnered with our network of physicians and patients allows us to provide unique insights into protocol design and creates opportunities to innovate within your pipeline.

  • image9

    Comprehensive Trial Operations

    Centralized coordinator staffing and clinical project management streamline your study, preventing variability-based errors and increasing protocol adherence.

  • Sponsor 2 - Data Driven Site Selection

    Data-Driven Site Network

    We identify and create the ideal sites for your protocol through robust querying of our EHR database and bespoke network build-outs. These queries directly inform feasibility estimates to generate accurate projections.

  • Sponsors 2 - Data Capture

    Data Capture and Analysis

    Pilot, our Direct Data Capture (DDC) platform, integrates CTMS, eSource and EDC all in one, eliminating transcription delays and enabling real-time source data verification.

  • Sponsors 2 - Recruitment

    Patient Centric Research

    Our model optimizes for patient experience. We improve access by bringing trials to patient communities, and tailor direct touchpoints to support patients from enrollment through completion.

3.2MM

TrialSpark’s existing network includes 900 physicians and 3.2 million patient lives.

50%

TrialSpark’s average screen failure rate is 50% lower than the US standard for comparable studies.

1.9x

TrialSpark sites recruit an average of 1.9x faster than other sites.

Bring your new treatments to more patients in less time

Today’s clinical trials hold the key to tomorrow’s life-changing treatments. Make your clinical trials available at more sites and to more patients all over the country.


Select Partners

We partner with the best. Join other life sciences companies bringing life-changing treatments to the market faster with TrialSpark.

Sponsor Logo - Pfizer
Sponsor Logo - Novartis
Sponsor Logo - Sanofi
Sponsor Logo - AstraZeneca
The amount of planning and analysis that goes into all of TrialSpark’s decision-making is truly unique. We just don’t see other partners with a composite EHR database to mine, real-world physicians to call, and an in-house clinical team to consult.

Clinical Development Lead

Biotech

TrialSpark expands access to new treatments for populations that have never been exposed to clinical trials as a treatment option. They deliver faster recruitment and diversify overall enrollment to ensure our therapies work for everyone.

CMO

Biotech